
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology demonstrates a strong financial performance, highlighted by a gross margin of 70.9% in the latest quarter, which exceeds both the previous year's margin and market expectations. The company's Clear Aligner revenue, while slightly below consensus at $794 million, reflects a commendable year-over-year growth in a competitive landscape, with hopes for a shift towards double-digit growth moving forward. Moreover, the increasing share of digital scans through iTero, comprising over half of all submissions for Invisalign cases, positions Align for continued growth and innovation in patient care and treatment efficiency.
Bears say
Align Technology is experiencing significant declines in clear aligner volumes, with a month-over-month drop of 15.9% from January to February, alongside a year-over-year decline of 12.2% on a same-store basis. The company’s bear case scenario projects flat to low-single digit revenue growth, with earnings per share growth constrained to the mid- to high-single digits, indicating potential pressures from macroeconomic factors and increasing competition. Additionally, the weakening growth trend for the patient cohort and the decline in new teen clear aligner cases further illustrate the challenges ahead, as revenue and EBITDA guidance for 2025 fell below consensus expectations, exacerbated by foreign exchange headwinds.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares